0001562180-18-004209.txt : 20181010 0001562180-18-004209.hdr.sgml : 20181010 20181010173940 ACCESSION NUMBER: 0001562180-18-004209 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181008 FILED AS OF DATE: 20181010 DATE AS OF CHANGE: 20181010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HILLEMAN JERYL L CENTRAL INDEX KEY: 0001216628 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36545 FILM NUMBER: 181116790 MAIL ADDRESS: STREET 1: C/O INTERSECT ENT, INC. STREET 2: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intersect ENT, Inc. CENTRAL INDEX KEY: 0001271214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 200280837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-641-2100 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SINEXUS INC DATE OF NAME CHANGE: 20031124 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-10-08 false 0001271214 Intersect ENT, Inc. XENT 0001216628 HILLEMAN JERYL L C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 false true false false Chief Financial Officer Common Stock 2018-10-08 4 M false 8167.00 11.12 A 31599.00 D Common Stock 2018-10-08 4 M false 4666.00 13.05 A 36265.00 D Common Stock 2018-10-08 4 S false 12833.00 27.9945 D 23432.00 D Stock Option (right to buy) 13.05 2018-10-08 4 M false 4666.00 0.00 D 2027-01-17 Common Stock 4666.00 65334.00 D Stock Option (right to buy) 11.12 2018-10-08 4 M false 8167.00 0.00 D 2024-06-10 Common Stock 8167.00 0.00 D Includes 20,500 Restricted Stock Units. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.81 to $28.24, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The vesting commencement date of the option is January 1, 2017. 12.5% of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months. The shares subject to the option vest commencing June 4, 2014. 25% of the shares subject to the option vested on June 4, 2015 and 1/48th of the shares subject to the option vests monthly thereafter over three (3) years. /s/ Jeryl L. Hilleman 2018-10-10